Summary: Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S.…
Virus
-
-
Covid DrugsPfizer
Pfizer and BioNTech aubmit for U.S. Emergency Use Authorization of an additional booster dose of their COVID-19 vaccine for older adults
by adminSummary : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the companies have…
-
Summary : AstraZeneca has failed in its bid to get US approval for its IL-5…
-
Synopsis : Pfizer Inc. (NYSE: PFE) Pfizer stands with the unified global community across the…
-
OmnicronPharma Science & Research
Mutations leading to omicron variant did not enable virus to fully escape immune system
by adminPeople who gained immunity – either through vaccination or exposure – against the original strain…
-
Summary : Results from a phase 3 trial evaluating AstraZeneca and Sanofi’s jointly developed treatment nirsevimab – the…
-
Summary: The U.S. Food and Drug Administration (FDA) has revised its emergency use authorization (EUA)…
-
Global MarketGsk
Medicago’s Plant-Based Vaccine Bolstered by GSK Adjuvant Wins First Approval
by adminSummary : Canada’s Medicago scored a regulatory first after Health Canada approved its plant-based COVID-19…
-
Summary : Moderna is poised to begin Phase III of its pivotal clinical trial for…
-
ChemIntelligenceGlobal Market
AstraZeneca in the News: EMA Greenlights RSV Vaccine, Leif Johansson Departing
by adminSummary : AstraZeneca and Sanofi secured accelerated authorization for respiratory syncytial virus (RSV) antibody nirsevimab…